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Feng Xue*, Ting-Bo Jiang, Bin Jiang, Xu-Jie Cheng, Yong-Ming He, Xun Li and Xiang-Jun YangAbstract
Background: Although cardiac troponin I gives excellent accuracy in the identification of myocardial necrosis, it
can also be elevated in a series of diseases other than acute coronary syndromes.
Case presentation: We present two cases of Chinese patients with a high serum troponin I level after an acute
episode of paroxysmal supraventricular tachycardia with normal coronary arteries via angiography.
Conclusion: Abnormal troponin elevations can be seen in patients presenting with paroxysmal supraventricular
tachycardia and angiographically-normal coronary arteries. Caution is advised with the use of invasive assessments
such as coronary angiography in the differential diagnosis of patients with paroxysmal supraventricular tachycardia
and elevated troponin levels.
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Cardiac troponin I (cTnI) is only detectable in adult car-
diac tissue [1]. It is a sensitive and specific biomarker con-
sistent with cardiac damage and plays a primordial role in
the diagnosis of patients with acute coronary syndromes
(ACS) [2]. A high cTnI level however is not synonymous
to ACS [3]. Patients with normal coronary arteries may
have elevated cTnI because of other diseases such as se-
vere congestive heart failure, myocarditis, cerebrovascular
accident, renal insufficiency and so on [4]. Since 2003 it
has been reported that patients suffering from paroxysmal
supraventricular tachycardia (PSVT) had elevated tropo-
nin levels [5]. Coronary angiography is often performed in
some patients presenting with PSVT because they have
chest pain and high troponin levels. Here, we report two
cases of PSVT-induced elevations in cTnI in the absence
of coronary artery disease.* Correspondence: szlongman@126.com
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Case 1
A 64-year-old Chinese male patient was admitted to our
hospital because of chest pain and palpitation on April 14,
2012. The symptoms lasted for forty-five minutes and
were relieved when he arrived at the hospital. He had no
history of hypertension, diabetes mellitus or other heart
diseases. The results of physical examination were normal.
His electrocardiogram showed ST segment depression >
1.0 mm in leads V3-6 (Figure 1A). The echocardiogram
showed no abnormal changes. The level of cTnI was
0.09 ng/ml (normal < 0.08 ng/ml). The next day this value
was up to 0.52 ng/ml. On the third day the value was
down to normal. He was diagnosed as ACS and treated
with aspirin, clopidogrel, low molecular weight heparin,
atorvastatin and so on. One week later the patient under-
went a coronary angiography which did not show us any
evidence for coronary artery obstruction (Figure 2A,B).
During electrocardiogram monitoring transient supra-
ventricular tachycardia was found. Then a transesopha-
geal electrophysiological study was carried on him. A
regular supraventricular tachycardia due to reentry
within the atrioventricular node was induced and termi-
nated (Figure 1B). At the 15th day of his hospitalization
he underwent a successful radiofrequency ablation.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Electrocardiographic images: The electrocardiogram of case 1 on the admission (A); The result of a transesophageal
electrophysiological study of case 1 (B); The result of a transesophageal electrophysiological study of case 2 (C). (EB: bipolar esophageal lead).
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tricular tachycardia and he was discharged with no fur-
ther treatments. During one-year follow-up he was well.
Case 2
A 66-year-old Chinese male patient with recurrent palpita-
tion for more than ten years was hospitalized with chief
complaint of chest pain and palpitation for eight hours on
Feb 27, 2013. A minimal response to sublingual nitrogly-
cerin was seen. There was no abnormal changes in theFigure 2 Angiographic images: The left coronary (A) and right coronaryelectrocardiogram and echocardiogram. The level of cTnI
was 0.16 ng/ml on admission. Nine hours later the value
was up to 2.28 ng/ml. He was also diagnosed as ACS and
received the same medicine as the first case. On the sec-
ond day after hospitalization he felt palpitation again. The
electrocardiogram showed supraventricular tachycardia
that was terminated by the transesophageal atrial pacing
(Figure 1C). The esophageal electrocardiogram demon-
strated that he had atrioventricular nodal reentrant tachy-
cardia. In order to determine if he had coronary artery(B) of case 1; The left coronary (C) and right coronary (D) of case 2.
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tient on Mar 1, 2013. Cardiac catheterization demonstrated
normal coronary arteries (Figure 2C,D). After undergoing a
radiofrequency ablation he was discharged from our hos-
pital. As of the time of this writing he has no sympotoms.
Discussion
Paroxysmal supraventricular tachycardia is a common
and generally benign arrhythmia. It rarely results in any
adverse clinical outcomes. But it was reported that 30%
of patients presenting with PSVT had significant tropo-
nin elevations [6]. Because these patients had symptoms
of chest pain and chest discomfort they were often mis-
diagnosed as ACS and given inappropriate treatments
such as antiplatelet and antithrombotic therapy. Coronary
angiography however revealed that most of them had nor-
mal coronary arteries. The mechanism of tachycardia-
induced troponin elevation is not fully understood [6].
Most authors are in agreement with the mechanism that
tachycardia increases myocardial oxygen demand, while it
decreases myocardial oxygen delivery because of short dia-
stole during which myocardial perfusion occurs. So tachy-
cardia ultimately leads to reduced myocardial perfusion
which results in the release of cTnI into the circulation [4].
What are the characteristics of patients with elevated tro-
ponins due to PSVT? We reviewed the English-language
scientific literature from the MEDLINE and ELSEVIER da-
tabases using the keywords “troponin” and“PSVT”. Most
authors found that patients with elevated troponins after
acute attack of PSVT were not at increased cardiovascular
risk such as hypertension, diabetes or dyslipidemia [6]. This
agrees with our cases. They also believed that the duration
of arrhythmia was not associated with troponin elevation
[7]. However, the maximal PSVT heart rate, ST-segment
depression ≥1 mm during the episode of PSVT and the
presence of impaired left ventricular systolic function were
correlated with troponin elevation [6,8].
Is coronary angiography necessary to be carried out in
these patients with PSVT which resulted in elevated tropo-
nins? Dorenkamp’s study replied this question [9]. In their
retrospective analysis troponin levels were increased in 14
of 114 patients. Thirteen of the 14 patients were subjected
to coronary angiography. The result was that no one had
significant coronary stenosis. They found a positive exer-
cise test was the best predictor of significant coronary ar-
tery disease and subsequent revascularization. A history of
hypertension and age 60 years or more ranked secondly.
So when we confronted a patient with PSVT and elevated
troponin, we should pay attention to his medical history in-
cluding cardiac risk factors and age. Then a noninvasive as-
sessment for coronary stenosis such as the exercise test
can be chosen before coronary angiography. This was not
implemented well in clinical practice according to our
cases and other reports.What is prognostic significance of elevated troponins in
these patients with PSVT? This question has different an-
swers. Calberg and his colleagues made a retrospective re-
view of 51 patients with PSVT, 38 of whom had cTnI
value meassured at least one time [4]. Eleven patients hav-
ing elevated cTnI were followed up for thirty days. They
found that none of patients had adverse cardiovascular
outcomes. On the contrary, Chow and his colleagues’ re-
search drew the conclusion that mild cTnI elevation in pa-
tients with PSVT was associated with increased risk of
future cardiovascular events such as death, myocardial in-
farction or cardiovascular rehospitalization [8]. They stud-
ied 78 patients including 29 patients with elevated cTnI.
The mean follow-up period was 2.2 ± 1.7 years. These two
retrospective studies had a common limitation that the
numbers of patients were too small for analysis. Both pro-
spective observational studies and larger retrospective
studies are recommended to answer this question.
Conclusions
Abnormal troponin elevations can be seen in patients pre-
senting with PSVT and angiographically normal coronary
arteries. Patients can not be diagnosed as ACS only be-
cause they have elevated troponins. Caution is advised
with the use of invasive assessments such as coronary
angiography in the differential diagnosis of patients with
PSVT and elevated troponins.
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